Experimental cancer drug injected directly into tumors in new trial
NCT ID NCT07395258
Summary
This early-stage study is testing a new cancer drug called BI 3923948 for the first time in people. It aims to find the highest safe dose when given alone or combined with an immunotherapy drug. The trial is for adults with advanced solid tumors that have spread and are accessible for injection, who have limited treatment options left.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CTR Leon Berard
Lyon, 69373, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Clinico De Valencia (INCLIVA)
Valencia, 46010, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital Clínic de Barcelona
Barcelona, 08036, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Indiana University
Indianapolis, Indiana, 46202, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut Gustave Roussy
Villejuif, 94800, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Karolinska Universitetssjukhuset Stockholm
Stockholm, 17177, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universitätsklinikum Heidelberg
Heidelberg, 69120, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.